ClinicalTrials.Veeva

Menu
L

Lapis Clinical Research, LLC | Specialties

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Metformin
Montelukast
Dupilumab
Fluvoxamine
Fluvoxamine 100
Ivermectin
Fluticasone
Olpasiran

Parent organization

This site is a part of Lapis Clinical Research, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Enrolling
Asthma
Drug: Placebo
Drug: Dupilumab

Trial sponsors

S
Amgen logo
Sanofi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems